SCHEMBL29533394

SCHEMBL29533394

C=Cc1ccc2cccc3c2c1C(=O)N3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ TGM2 P21980 3/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ SIRT1 Q96EB6 1/20 0.35
▸ CES1 P23141 1/20 0.34
▸ FLT3 P36888 3/20 0.34
▸ ATG4B Q9Y4P1 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ RET P07949 1/20 0.33
▸ MAP3K7 O43318 1/20 0.33
▸ TAB1 Q15750 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MITF O75030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317499 1.00 KMT2A (0.38) KMT2APARP1TGM2SIRT2SIRT1
Pyridine SCHEMBL28009697 0.75 PARP1 (0.47) KMT2APARP1CES1MAPTALDH1A1
SCHEMBL11318564 0.75 KMT2A (0.45) KMT2APARP1CES1MAPTALDH1A1
SCHEMBL7936537 0.75 RAD52 (0.44) KMT2APARP1CES1MAPTALDH1A1
SCHEMBL24317500 0.75 CDK2 (0.44) KMT2APARP1CES1ATG4BMAPT
SCHEMBL10905704 0.73 KMT2A (0.40) KMT2APARP1CES1ATG4BMAPT
SCHEMBL10865297 0.72 KMT2A (0.42) KMT2APARP1CES1ATG4BMAPT
SCHEMBL24317498 0.71 MAPT (0.43) KMT2APARP1MAPTALDH1A1HTT
SCHEMBL29532490 0.71 MAPT (0.43) KMT2APARP1MAPTALDH1A1HTT
SCHEMBL11838515 0.71 KMT2A (0.38) KMT2APARP1CES1ATG4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228624-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
Send feedback